Loading
Total declarations
Companies
▲ Purchases (728 ops.)
▼ Sales (904 ops.)
Latest filing published 24 Feb 2009 for NORTH AMERICAN SCIENTIFIC INC, €431.
Filing timeline
BuySaleMichael Roth
First 200 filings with a declared amount
Insider track record
Disclosed buys
728
Disclosed sells
904
Signal history
No signal scores available.
Closed purchases
Market purchases
728
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Roth: trading record in brief
Michael Roth discloses dealings in 9 companies, chiefly Multi Fineline Electronix Inc, Curon Medical Inc and Cellstar Corp. In total, 1,633 filings cover trades dated from 28 February 2006 to 24 February 2009.
Market trades split into 728 purchases (€31.3M) and 904 sales (€43.9M). Taken together, the sales exceed the purchases by €12.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2009: no purchases and 12 sales on the market.
In size, the median ticket on the buying side is €17k.
On 24 February 2009 came the latest disclosure, an open-market sale for €33 in North American Scientific Inc. The clock since the last published purchase (16 June 2008) now reads 6,703 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Roth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1,631 total
4,650 shares@ US$0.12Common Stock, $0.01 par value per shareSEC:0001169232-09-001144:0
350 shares@ US$0.12Common Stock, $0.01 par value per shareSEC:0001169232-09-001144:1
6,928 shares@ US$0.12Common Stock, $0.01 par value per shareSEC:0001169232-09-001144:2
2,800 shares@ US$0.18Common Stock, $0.001 par value per shareSEC:0001169232-09-001108:0
1,000 shares@ US$0.71Common Stock, $0.01 par value per shareSEC:0001169232-09-001068:0
14,200 shares@ US$0.63Common Stock, $0.01 par value per shareSEC:0001169232-09-001068:2
50,000 shares@ US$0.50Common Stock, $0.01 par value per shareSEC:0001169232-09-001068:3
6,664 shares@ US$0.16Common Stock, $0.01 par value per shareSEC:0001169232-09-001047:0
60 shares@ US$0.14Common Stock, $0.01 par value per shareSEC:0001169232-09-001047:1
15,363 shares@ US$0.14Common Stock, $0.01 par value per shareSEC:0001169232-09-001047:2
13,478 shares@ US$0.43Common Stock, $0.001 par value per shareSEC:0001140361-09-001429:0
77,400 shares@ US$1.0488Common Stock, $0.001 par value per shareSEC:0001140361-08-022735:0
184,376 shares@ US$0.2129Common Stock, $0.50 par value per shareSEC:0001140361-08-021763:0
195,000 shares@ US$0.2064Common Stock, $0.50 par value per shareSEC:0001140361-08-021763:1
250,000 shares@ US$0.2559Common Stock, $0.50 par value per shareSEC:0001140361-08-021763:2
500 shares@ US$0.25Common Stock, $0.50 par value per shareSEC:0001140361-08-021763:3
2,600 shares@ US$2.10Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:0
1,000 shares@ US$2.09Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:1
100 shares@ US$2.085Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:2
6,400 shares@ US$2.08Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:3
400 shares@ US$2.077Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:4
9,200 shares@ US$2.07Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:5
300 shares@ US$2.065Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:6
3,200 shares@ US$2.06Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:7
6,560 shares@ US$2.05Common Stock, $0.001 par value per shareSEC:0001140361-08-018710:8
25 of 1631 declarations
